TENXのチャート
TENXの企業情報
| symbol | TENx |
|---|---|
| 会社名 | Tenax Therapeutics Inc （テナックス・セラピュ―ティックス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Commercial Physical_Biological Resarch |
| 業種 | バイオテクノロジ―_メディカルリサ―チ 医療関連（Health Care） |
| 概要 | 事業概要 テナックス・セラピュティクス（Tenax Therapeutics Inc） (旧名：Oxygen Biotherapeutics Inc)は特定の標的組織への酸素運搬を中心としたバイオテクノロジー製品の開発事業に従事する。同社は全身性パーフルオロカーボン（PFC）製品「Oxycyte」を開発している。それ以外、同社は個人医療、局部創傷治癒、局部適応症などに使用されるパーフルオロカーボンをベースとする一連の酸素担体を開発した。同社はまた、「Dermacyte」及び「Wundecyte」という局所製品の開発に注力する計画がある。同社は「Vitavent」という肺疾患を治療する開発中の酸素交換液体がある。同社はまた、皮下液体に含まれるグルコースレベルを測定する酵素プロセスを利用するバイオセンサ移植組織片製品に対する権利を有する。同社は、付加的な臨床研究プロトコールを開発し、座瘡の治療、酒さ、かゆみ、乾癬、および皮膚炎などの局所の徴候のための概念実証研究を実施する予定がある。 テナックス・セラピュ―ティックスは、米国の製薬会社。心拍出量症候群を発症する危険性の心臓手術患者における罹患率および死亡率の低減に使用するレボシメンダンを含むクリティカル・ケア市場向けの医薬製品の開発・商品化を展開する。製品は、｢Oxycyte｣、｢Dermacyte｣、｢Wundecyte｣がある。 Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need. The Company has a world-class scientific advisory team including recognized global experts in pulmonary hypertension. The Company owns North American rights to develop and commercialize levosimendan and has recently released topline data regarding their Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Tenax plans to advance a delayed release oral formulation of imatinib, designed to avoid the gastric irritation, into a single pivotal trial pursuant to the 505(b)(2) pathway. |
| 本社所在地 | ONE Copley Parkway Suite 490 Morrisville NC 27560 USA |
| 代表者氏名 | Ronald R. Blanck ロナルド・R・ブランク |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 919-806-4414 |
| 設立年月日 | 24593 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 11人 |
| url | www.tenaxthera.com |
| nasdaq_url | https://www.nasdaq.com/symbol/tenx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -5.79296 |
| 終値（lastsale） | 5.24 |
| 時価総額（marketcap） | 7679199.04 |
| 時価総額 | 時価総額（百万ドル） 7.47403 |
| 売上高 | 売上高（百万ドル） 0.00000 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 1.06688 |
| 当期純利益 | 当期純利益（百万ドル） -5.62933 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Tenax Therapeutics Inc revenues was not reported. Net loss decreased 51% to $3.1M. Lower net loss reflects Other Research and development decrease of 91% to $296K (expense) Personnel costs decrease of 17% to $1.6M (expense) Legal and professional fees decrease of 19% to $845K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$4.44 to -$2.12. |
TENXのテクニカル分析
TENXのニュース
Current Momentum Stock: Tenax Therapeutics, Inc. (NASDAQ:TENX -23.98%), Uber Technologies, Inc. (NYSE:UBER 0.11%) 2023/02/03 16:55:15 Stock Equity
Tenax Therapeutics, Inc. (NASDAQ:TENX) with the stream of -23.98% also noticed, India Uber Technologies, Inc. (NYSE:UBER) encountered a rapid change of 0.11% in the last hour of Friday’s trading session. … The post Current Momentum Stock: Tenax Therapeutics, Inc. (NASDAQ:TENX -23.98%), Uber Technologies, Inc. (NYSE:UBER 0.11%) appeared first on Stocks Equity .
Ford Motor, Atlassian, Bill.com among premarket losers'' pack 2023/02/03 13:46:10 Seeking Alpha
Edible Garden EDBL -43% on pricing $10.2M underwritten offering.MDxHealth (MDXH) -38%.Gaucho Group (VINO) -37%.Tenax Therapeutics TENX -29% after pricing $15.6M securities…
Tenax Therapeutics stock dips after pricing $15.6M securities offering 2023/02/03 13:27:00 Seeking Alpha
Tenax Therapeutics (TENX) shares fell 14% after the pharmaceutical company priced its $15.6M securities offering.The offering comrpises 8.66M shares of common stock (or pre-funded…
Tenax Therapeutics Announces Pricing of Approximately $15.6 Million Public Offering 2023/02/03 13:19:00 GlobeNewswire
CHAPEL HILL, N.C., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, announced today the pricing of a public offering of (i) 8,666,666 shares of its common stock (or pre-funded warrants in lieu thereof) and (ii) warrants to purchase up to 17,333,332 shares of its common stock (the “Public Warrants”) at a purchase price of $1.80 per share and associated Public Warrant. The Public Warrants will have an exercise price of $2.25 per share, are immediately exercisable, and will expire five years after their initial exercise date. The offering is expected to close on or about February 7, 2023, subject to customary closing conditions.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday 2023/02/03 12:34:29 InvestorPlace
Source: Shutterstock It’s time to start the final day of trading this week with a look at the biggest pre-market stock movers for Friday! Moving stocks are SEC filings, public offerings, earnings, and more. Let’s jump into that news below! Pre-Market Stock Movers: 10 Top Gainers Reshape Lifesciences (NASDAQ: RSLS ) stock is rocketing more than 204% following a mixup concerning recent SEC filings . Genetic Technologies (NASDAQ: GENE ) shares are soaring over 178% after revealing plans for new cancer tests . Magenta Therapeutics (NASDAQ: MGTA ) stock is surging more than 37% after announcing it will explore strategic alternatives . Nordstrom (NYSE: JWN ) shares are gaining 29%on reports Ryan Cohen is taking a stake in the company. Sidus Space (NASDAQ: SIDU ) stock is increasing 27% after closing its public offering . Bright Green (NASDAQ: BGXX ) shares are climbing over 21% after announcing plans to raise $500 million . Processa Pharma (NASDAQ: PCSA ) stock is rising 18% on Friday morning.
Tenax Therapeutics news: Company executes reverse stock split | WRAL TechWire 2023/01/06 14:08:24 WRAL TechWire
Tenax Therapeutics executed a long planned reverse stock split earlier this week. Shares trade under the symbol TENX.
Gratifying stocks: Tenax Therapeutics, Inc. (NASDAQ:TENX -6.68%), Ambev S.A. (NYSE:ABEV 1.35%) 2023/01/04 22:45:39 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Gratifying stocks: Tenax Therapeutics, Inc. (NASDAQ:TENX -6.68%), Ambev S.A. (NYSE:ABEV 1.35%) appeared first on Stocks Equity .
Today’s watch list includes Tenax Therapeutics Inc. (NASDAQ:TENX) stock 2023/01/04 17:08:00 US Post News
In the current trading session, Tenax Therapeutics Inc.’s (TENX) stock is trading at the price of $0.11, a fall of -4.34% over last night’s close. So, the stock is trading at a price that is -92.74% less than its 52-week high of $1.46 and 32.37% better than its 52-week low of $0.08. Based on the […]
Why Is Tenax Therapeutics (TENX) Stock On the Move Today? 2023/01/04 16:01:23 InvestorPlace
Tenax Therapeutics (TENX) stock is on the move Wednesday after the company announced plans for a one-for-20 reverse stock split.
Tenax Therapeutics to execute 1-for-20 reverse stock split 2023/01/04 13:37:33 Seeking Alpha
Tenax Therapeutics (TENX) is set to implement a 1-for-20 reverse stock split of its outstanding shares of common stock.Every 20 shares of company common stock will be automatically…
Is The Stock A Good Investment? Tenax Therapeutics, Inc. (NASDAQ:TENX), Verb Technology Company, Inc. (NASDAQ:VERB) 2022/12/06 01:11:06 Stock Equity
Tenax Therapeutics, Inc. (TENX) with the stream of 3.19% also noticed, India Verb Technology Company, Inc. (VERB) encountered a rapid change of -7.09% in the last hour of Monday’s trading … The post Is The Stock A Good Investment? Tenax Therapeutics, Inc. (NASDAQ:TENX), Verb Technology Company, Inc. (NASDAQ:VERB) appeared first on Stocks Equity .
Tenax Therapeutics Inc. (NASDAQ:TENX) Shares Surges 15.00% In A Week – But Can It Keep Rising? 2022/11/25 12:00:00 Marketing Sentinel
In last trading session, Tenax Therapeutics Inc. (NASDAQ:TENX) saw 6.42 million shares changing hands with its beta currently measuring 1.95. Company’s recent per share price level of $0.14 trading at $0.02 or 11.29% at ring of the bell on the day assigns it a market valuation of $4.91M. That closing price of TENX’s stock is … Tenax Therapeutics Inc. (NASDAQ:TENX) Shares Surges 15.00% In A Week – But Can It Keep Rising? Read More »
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday 2022/11/21 10:58:38 Benzinga
Gainers AGBA Group Holding Limited (NASDAQ: AGBA ) gained 50.7% to close at $6.78 on Friday. FOXO Technologies Inc. (NYSE: FOXO ) shares surged 46.9% to close at $0.6520 on Friday. Foxo Technologies recently announced management changes and delayed filing of Form 10Q. PaxMedica, Inc. (NASDAQ: PXMD ) jumped 37.4% to close at $2.13 on Friday after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Mercurity Fintech Holding Inc. (NASDAQ: MFH ) gained 32.9% to close at $1.05. Yatra Online, Inc. (NASDAQ: YTRA ) shares surged 32.6% to close at $2.81. Yatra Online''s Indian subsidiary, Yatra Online Limited, received the final observation from the Securities and Exchange Board of India. The company also announced that it will report its Q2 financial results on Tuesday, November 29, 2022. Stryve Foods, Inc. (NASDAQ: SNAX ) gained 28.6% to settle at $0.6431. Stryve Foods recently reported worse-than-expected Q3 sales results. Conformis, Inc. (NASDAQ: CFMS ) rose 28.5% to close at $2.03.
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday 2022/11/16 10:01:25 Benzinga
Gainers Satixfy Communications Ltd. (NYSE: SATX ) shares gained 140.7% to settle at $31.80 on Tuesday. Tenax Therapeutics, Inc. (NASDAQ: TENX ) jumped 45.7% to close at $0.1351 on Tuesday. Exagen Inc. (NASDAQ: XGN ) rose 42.4% to close at $2.99 following upbeat Q3 results. Gelesis Holdings, Inc. (NYSE: GLS ) gained 40% to settle at $0.5090. Gelesis Holdings recently posted Q3 sales of $6.44 million. 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) climbed 38.6% to close at $18.69 after Goldman Sachs upgraded the stock from Neutral to Buy and announced a $68 price target. HUYA Inc. (NYSE: HUYA ) gained 38.3% to close at $3.18 after the company reported better-than-expected Q3 results. WiMi Hologram Cloud Inc. (NASDAQ: WIMI ) rose 37.3% to settle at $0.7951. Sea Limited (NYSE: SE ) shares jumped 36.1% to settle at $62.31 after the company reported better-than-expected Q3 results. SenesTech, Inc. (NASDAQ: SNES ) shares climbed 35.8% to close at $0.1949 on Tuesday. SenesTech reported a 1-for-20 reverse stock split.
US stocks closed higher, Dow Jones up 0.17% 2022/11/16 02:54:50 InstaForex
At the close of the New York Stock Exchange, the Dow Jones rose 0.17%, the S&P 500 rose 0.87% and the NASDAQ Composite rose 1.45%. Walmart Inc was the top performer among the components of the Dow Jones index today, up 9.05 points or 6.54% to close at 147.44. Nike Inc rose 2.32 points or 2.22% to close at 106.71. Salesforce Inc rose 3.41 points or 2.15% to close at 162.07. The least gainers were UnitedHealth Group Incorporated, which shed 10.74 points or 2.09% to end the session at 503.01. The Travelers Companies Inc was up 1.75% or 3.20 points to close at 179.50 while Verizon Communications Inc was down 1.59% or 0.61 points to close at 37.70. Leading gainers among the S&P 500 index components in today''s trading were SVB Financial Group, which rose 9.18% to 239.93, Ceridian HCM Holding Inc, which gained 8.30% to close at 72.68. as well as Match Group Inc, which rose 6.66% to end the session at 51.92. The least gainers were Capital One Financial Corporation, which shed 7.18% to close at 103.56.